Spelling suggestions: "subject:"mucus"" "subject:"fucus""
121 |
Mucus-penetrating polymersomes as a potential lung drug delivery system: preparation, in vitro characterization, and biodistribution tests / Mucus-penetrating polymersomes as a potential lung drug delivery system: preparation, in vitro characterization, and biodistribution testsMiranda, Beatriz Nogueira Messias de 28 September 2018 (has links)
O muco protege o corpo humano de partículas externas, mas também representa uma barreira para a entrega de controlada de medicamentos através de nanocarregadores. Para ultrapassar a barreira do muco e impedir mucoadesão, nanopartículas sólidas são normalmente revestidas com polímeros inertes, tais como o polietileno glicol (PEG). No entanto, trata-se de um procedimento relativamente complexa. Nesta tese, estudamos métodos para fabricar nanocarreadores com uma excepcional combinação de propriedades, incluindo uma boa capacidade de mucopenetração e uma grande capacidade de carga. Ao contrário dos métodos convencionais de revestimento, usamos um copolímero dibloco, que consiste em dois blocos hidrofóbicos e hidrofílicos, que se auto-organiza em polimerosomos sob hidratação. Devido à inércia do bloco hidrofílico, estes polimerosomos devem ser, por natureza, muco penetradores. Além disso, sua estrutura oca fornece os polimersomos para serem carregados com carga hidrofílica, enquanto a carga hidrofóbica pode ser transportada através da membrana. Por conta da utilização de um polímero hidrolisável na presença de ácido, ácido poli láctico (PLA) como a espinha dorsal copolímero, demonstramos que estes polimerosomos podem liberar o conteúdo, após aplicação do estímulos externo relacionado ao pH. Os experimentos de rastreamento de partículas demonstraram que os polimersomos se difundem mais rápido do que as partículas não revestidas, em muco de intestino de porco, e testes de biodistribuição apresentaram resultados encorajadores para a entrega localizada de fármacos de maneira mais homogênea, melhorando a biodisponibilidade e efeitos terapeuticos. Mais estudos relacionados ao aumento da eficiência de encapsulação e testes de efetividade in vivo no tratamento de doenças devem ser promovidos. Acreditarmos que combinação das vantagens relacionadas à estrutura vesicular dos polimerossomas, estabilidade, e muco penetração possibilitam o desenvolvimento de uma nova plataforma para a entrega controlada de medicamentos na mucosa. / Mucus protects the human body by trapping foreign particulates but also poses a barrier for drug delivery by slowing down the mobility of drug carriers. To design mucus penetrating carriers, solid particles are typically coated with inert polymers such as polyethylene glycol (PEG) to prevent mucoadhesion. However, the solid structure of these particles limits their loading capabilities and the process to coat them requires a complex synthesis. In this thesis we studied methods to fabricate nanocarriers with an exceptional combination of properties including a good mucus-penetration capability and loading capacity of hydrophilic and hydrophobic cargos. Unlike conventional coating methods, we use a diblock copolymer, consisting of both hydrophobic and hydrophilic blocks, which self-assembles into polymersomes under hydration. Because of the inertness of the hydrophilic block, these polymersomes should be mucus-penetrating by nature. Moreover, their hollow structure provides the polymersomes to be loaded with hydrophilic cargo, whereas hydrophobic cargo can be carried through the membrane. Importantly, by using a hydrolysable acid-catalyzed polymer (poly lactic acid, PLA) as the copolymer backbone, we demonstrate that these polymersomes can release contents upon application of external pH stimuli. Particle Tracking experiments demonstrated that polymersomes diffuse faster than uncoated particles in porcine intestine mucus, and biodistribution tests displayed encouraging results towards more homogeneous local drug-delivery, helping bioavailability as well as therapeutic efects. More studies related to the increase of encapsulation efficiency, and in vivo disease treatment tests should be promoted. Although we believe that combining the advantages of polymersome carrier, and tunning the membrane composition, this mucus-penetrating carrier we propose may provide as a new platform for mucosal drug delivery.
|
122 |
Rheological behavior and nano-microstructure of complex fluids: Biomedical and Bitumen-Heavy oil applicationsHasan, MD. Anwarul 11 1900 (has links)
The main objective of this research was to exploit the interrelations between the rheological behavior and nano-microstructure of complex fluids in solving two state-of-the-art problems, one in the field of biomedical engineering: controlling the amount and characteristics of bioaerosol droplets generated during coughing, and the other in the bitumen-heavy oil industry: characterizing the nano-microstructure of asphaltene particles in bitumen and heavy oil from their rheological behavior.
For the first problem, effect of viscoelastic and surface properties of artificial mucus simulant gels on the size distribution and amount of airborne bioaerosol droplets generated during simulated coughing were investigated. The results revealed that suppressing the generation of bioaerosol droplets and/or reducing the number of emitted droplets to a minimum during coughing are practically achievable through modulation of mucus viscoelastic properties. While variation of surface tension did not show any change in the droplet size distribution, an increase in particle size was observed as the samples changed from elastic solid type to viscoelastic type to viscous fluid type samples. This knowledge will help in the development of a new class of drugs being developed at the University of Alberta, aimed at controlling the transmission of airborne epidemic diseases by modifying the viscoelastic properties of mucus.
For the second problem, studies of viscoelastic behavior of Athabasca bitumen (Alberta) and Maya crude (Mexico) oil samples, along with their Nano-filtered and chemically separated-plus-reconstituted samples were performed. The results revealed that the rheological behaviors of the bitumen-heavy oil samples are governed by their multiphase nature. The rheological behavior of all feeds, permeates and retentate samples followed a single master curve over the entire temperature interval, consistent with that of a slurry comprising a Newtonian liquid plus a dispersed solid comprising non-interacting hard spheres. The behavior of asphaltenes in the reconstituted samples, however, was found to be significantly different from that in nanofiltered samples.
The information about the characteristics and behaviors of asphaltenes obtained in this study will help better understand the asphaltene structures, and support the effort to determine solutions for numerous asphaltene-related industrial problems. In the long run, this knowledge will help to create more efficient extraction and upgrading processes for bitumen and heavy oils. / Thermo Fluids
|
123 |
Rheological behavior and nano-microstructure of complex fluids: Biomedical and Bitumen-Heavy oil applicationsHasan, MD. Anwarul Unknown Date
No description available.
|
124 |
Dissociation of hexavalent chromium from primer paint particles into simulated mucus fluid /Moran, Michael Patrick. January 2005 (has links) (PDF)
Thesis (M.S.)--Uniformed Services University of the Health Sciences, 2005. / Typescript (photocopy).
|
125 |
Avaliação da atividade anti-inflamatória intestinal da dieta enriquecida com farinha de banana prata verde (Musa sp AAB) no modelo de inflamação intestinal induzida por TNBS em ratosCosta, Erika Ferreira January 2018 (has links)
Orientador: Luiz Claudio Di Stasi / Resumo: A Doença Inflamatória Intestinal (DII) é uma doença inflamatória crônica e idiopática do intestino que inclui duas doenças distintas: a Doença de Crohn e a Retocolite Ulcerativa. Os pacientes acometidos pela DII podem sofrer de dor abdominal, diarreia e de outros sintomas socialmente inaceitáveis que comprometem sua qualidade de vida. Embora exista uma grande quantidade de fármacos destinados ao tratamento da DII, fatores como o alto custo de aquisição, os efeitos colaterais e o fato de uma parte dos pacientes não responderem inicialmente ao tratamento, têm despertado o interesse de pesquisadores na busca de novas abordagens de tratamento para a doença. Uma das alternativas é a utilização de produtos naturais com propriedades antioxidante e/ou imunomoduladora, assim como de produtos que possam modular a microbiota intestinal, prevenindo recidivas ou complementando o tratamento de pacientes acometidos pela DII. Com base nisso, estudos realizados por nosso grupo de pesquisa com a farinha de banana nanica verde (Musa sp AAA) demonstraram que a espécie apresentou um efeito anti-inflamatório intestinal. Considerando a similaridade química, a espécie Musa sp AAB (banana prata) foi selecionada para a realização do presente estudo. As bananas são ricas em fibras, amido resistente e fenóis, além de apresentarem alto valor nutricional por serem excelentes fontes de potássio, cálcio, fósforo e vitaminas A, B e C. De forma geral, as bananas apresentam atividades antidiarreica, antiulcero... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Inflammatory bowel disease (IBD) is a chronic and idiopathic inflammation of gastrointestinal tract that comprises two major disorders: Crohn's Disease and Ulcerative Colitis. Patients affected by IBD may suffer abdominal pain, diarrhea and other socially unacceptable symptoms that compromise their quality of life. Although there are a large number of drugs for the treatment of IBD, factors such as the high cost of acquisition, side effects and the fact that many patients do not respond initially to the available treatment, have aroused the interest of researchers to evaluate new therapeutic approaches to disease. One of these alternatives is the use of natural products with antioxidant and/or immunomodulatory properties, as well as products which can modulate the intestinal microbiota, preventing relapses or complementing patient treatments. Based on this, our research group conducted studies with green dwarf banana flour (Musa sp AAA) and demonstrated its intestinal anti-inflammatory effect. Bananas are rich in fiber, resistant starch and phenols, and have high nutritional value as they are excellent sources of potassium, calcium, phosphorus and vitamins A, B and C. Generally, bananas present antidiarrheal, antiulcerogenic, antimicrobial, hypoglycemic, antihypertensive, antihypertensive and diuretic activities. Indeed, Musa sp AAA variety increased the production of SCFAs probably because they produce prebiotic effects due to the presence of fibers and resistant starch in i... (Complete abstract click electronic access below) / Mestre
|
126 |
Évaluation de l’endométrite clinique chez la vache laitière et efficacité d’un traitement de céfapirine sous forme d’une infusion intra-utérineTison, Nicolas 12 1900 (has links)
No description available.
|
127 |
Histamina induz inflamação das vias aéreas e produção de muco em pulmão de camundongos / Histamine induces airway inflammation and mucus production in lung tissue of miceVieira, Letícia Vilma dos Santos [UNESP] 07 August 2017 (has links)
Submitted by LETICIA VILMA DOS SANTOS VIEIRA null (leticiavieir@hotmail.com) on 2017-09-22T15:22:13Z
No. of bitstreams: 1
DISSERTAÇÃO_Letícia Vilma dos Santos Vieira.pdf: 2517417 bytes, checksum: 934c0060d04d2bb79afa7cb1c1f7b10a (MD5) / Approved for entry into archive by Monique Sasaki (sayumi_sasaki@hotmail.com) on 2017-09-27T18:54:34Z (GMT) No. of bitstreams: 1
vieira_lvs_me_araca.pdf: 2517417 bytes, checksum: 934c0060d04d2bb79afa7cb1c1f7b10a (MD5) / Made available in DSpace on 2017-09-27T18:54:34Z (GMT). No. of bitstreams: 1
vieira_lvs_me_araca.pdf: 2517417 bytes, checksum: 934c0060d04d2bb79afa7cb1c1f7b10a (MD5)
Previous issue date: 2017-08-07 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Na inflamação alérgica, a histamina desencadeia papel crucial na indução de sintomas, tais como vasodilatação, broncoconstrição e produção de muco. O objetivo deste estudo foi investigar os efeitos da histamina na inflamação e no remodelamento das vias aéreas, avaliando para tanto a produção de muco e colágeno em modelo murino de inflamação pulmonar. Camundongos Balb/c machos de 20-25g foram estimulados, por via intratraqueal, com histamina em diferentes concentrações (10, 50 e 100 µM) e avaliados após 6, 24 e 48 horas. A partir dos dados resultantes do ensaio dose-resposta, foi realizado tratamento farmacológico, onde animais foram separados em 5 grupos (6 camundongos por grupo): Grupo 1 (PBS), controle não estimulado; Grupo 2 (Histamina), controle estimulado; Grupo 3 (Histamina + Loratadina); Grupo 4 (Histamina + Dexametasona) e Grupo 5 (Histamina + Dexametasona e Loratadina). Analisamos a migração de leucócitos no lavado broncoalveolar (LBA) e no tecido pulmonar. As alterações estruturais no tecido pulmonar e na traqueia foram avaliadas por análise histopatológica, bem como a produção de muco e deposição de colágeno usando Alcian blue/Periodic Acid Shiff e Tricômio de Masson, respectivamente. O sobrenadante do LBA e o tecido pulmonar foram coletados para quantificar os níveis SCF e CCL3 por ELISA de captura. A expressão gênica de Muc5ac, Gob-5, Col1a2 e receptores de histamina foi avaliada por RT-PCR em tempo real. Nossos resultados demonstram que a histamina induz inflamação das vias aéreas, com presença de infiltrado leucocitário no LBA e no tecido pulmonar. Além disso, os animais estimulados com histamina demonstraram aumento significativo na expressão gênica de Muc5ac, Gob-5 e Col1a2 no tecido pulmonar, produção SCF e CCL3 no LBA e pulmão, bem como apresentaram alterações estruturais na traqueia e no tecido pulmonar, tais como infiltrado leucocitário, presença de células caliciformes, produção de muco e depósito de colágeno. O pré-tratamento com dexametasona (DEX) inibiu a migração leucocitária no LBA e tecido pulmonar, e também diminuiu a expressão gênica de Muc5ac no tecido pulmonar, diminuiu a produção de SCF e CCL3 no LBA e pulmão, bem como reduziu a produção de muco e a deposição de colágeno no pulmão. Já o pré-tratamento com loratadina (LOR), bloqueador de H1, inibiu parcialmente a migração celular no LBA, mas não no tecido pulmonar, enquanto que a associação farmacológica entre DEX e LOR diminuiu significativamente a migração leucocitária tanto no LBA como no tecido pulmonar. Com base nos dados acima, sugere-se que a histamina induz inflamação das vias aéreas, promovendo a migração de leucócitos possivelmente através da produção de SCF e CCL3, bem como provoca alterações estruturais na traqueia e no tecido pulmonar, tais como produção de muco, deposição de colágeno, e esses efeitos tem a participação dos receptores H1 e H4. / In allergic inflammation, histamine exerts a crucial role in the induction of symptoms, such as vasodilation, bronchoconstriction and mucus production. The aim of this study was to investigate the effects of histamine in inflammation and airway remodeling, evaluating the mucus production and collagen in a murine model of pulmonary inflammation. Male Balb/c mice of 20-25g were challenged by intratracheal instillation of histamine at different concentrations (10, 50 and 100 μM) and evaluated after 6, 24 and 48 hours. From the data resulting from the dose-response assay, pharmacological treatment was performed, and animals were separated into 5 groups (6 mice per group): Group 1 (PBS), non-challenged control; Group 2 (Histamine), challenged control; Group 3 (Histamine + Loratadine); Group 4 (Histamine + Dexamethasone) and Group 5 (Histamine + Dexamethasone and Loratadine). We analyzed the recruitment of leukocytes in bronchoalveolar lavage (BAL) and lung tissue. Structural changes in lung tissue and trachea were assessed by histopathological analysis, as well as mucus production and collagen deposition using Alcian blue/Periodic Acid Shiff and Masson's Trichrome, respectively. BAL supernatant and lung tissue were collected for SCF and CCL3 levels quantification by capture ELISA. The gene expression of Muc5ac, Gob-5, Col1a2, and histamine receptors was evaluated by RT-PCR real time. Our results demonstrated that histamine induces airway inflammation, with presence of leukocyte infiltrate in BAL and lung tissue. In addition, histamine-challenged animals demonstrated a significant increase in the gene expression of Muc5ac, Gob-5 and Col1a2 in lung tissue, SCF and CCL3 production in BAL and lung, as well as structural changes in the trachea and lung tissue, such as leukocyte infiltrate, presence of goblet cell, mucus production and collagen deposition around the airways. Dexamethasone pre-treatment (DEX) inhibited leukocyte recruitment in BAL and lung tissue, decreased gene expression of Muc5ac in lung tissue, decreases SCF and CCL3 production in BAL and lung, as well as mucus production and collagen deposition in the lung. Already pre-treatment with loratadine (LOR), an H1 blocker, partially inhibited cell migration in BAL, but not in lung tissue, whereas the pharmacological association between DEX and LOR significantly reduced leukocyte recruitment in both the BAL and the lung tissue. Putting the above data together, we suggest that histamine induces airway inflammation, promoting the recruitment of leukocytes possibly through the production of SCF and CCL3, as well as causes structural changes in the trachea and lung tissue, such as mucus production, collagen deposition, and these effects might be mediated by H1 and H4 receptors.
|
128 |
Efeito da ventilação não invasiva com pressão positiva contínua nas vias aéreas de pacientes oncológicos / Effects of noninvasive ventilation with continuous positive pressure on the airways of oncologic patientsGabriela Marcon Manfrim 26 September 2008 (has links)
INTRODUÇÃO: A insuficiência respiratória acomete grande parte dos pacientes oncológicos levando a altos índices de mortalidade. A ventilação não invasiva (VNI) pode auxiliar seu manejo, mas seus efeitos ainda são pouco conhecidos sobre os mecanismos de defesa pulmonar. OBJETIVOS: Observar o efeito da VNI com máscara facial usando-se geradores de fluxo com pressão positiva contínua (CPAP) e ventilador microprocessado no modo pressão de suporte + pressão positiva ao final da expiração (PSV + PEEP), a fim de verificar impacto nas propriedades viscoelásticas do muco respiratório e o conforto proporcionado ao paciente. MÉTODOS: A VNI foi instalada após diagnóstico de insuficiência respiratória em dezenove pacientes, admitidos nas unidades de tratamento intensivo do Hospital A. C. Camargo, sendo nove submetidos ao CPAP e dez com PSV + PEEP. Foram colhidos antes e após uma hora de VNI: os dados clínicos, secreção nasal, gasometria, e o grau de conforto através de uma escala visual. As propriedades físicas do muco (transportabilidade in vitro, adesividade e wettabilidade ou hidrofobicidade) foram avaliadas respectivamente no palato de rã, máquina da tosse e ângulo de contato. RESULTADOS: Os grupos eram homogêneos entre si em relação à idade, sexo, tipo e estadiamento do tumor e SAPS II. Em relação às propriedades físicas do muco, houve um aumento da transportabilidade in vitro do muco nasal com o sistema PSV + PEEP (p = 0,04) e um aumento na wettabilidade no grupo CPAP (p = 0,06). Os dois sistemas foram eficazes em melhorar significativamente os sinais vitais, a PaO2/FiO2, o padrão e o conforto respiratório e em evitar a intubação traqueal nas primeiras 24 horas (p < 0,05). Entretanto, independentemente do tipo de sistema de VNI usado, foram encontrados altos índices de intubação endotraqueal e mortalidade no seguimento destes pacientes. CONCLUSÃO: As propriedades físicas do muco (transportabilidade in vitro e wettabilidade) se alteraram após uma hora de uso da VNI e parecem ser dependentes da temperatura e umidificação dentro da máscara. A VNI mostrou-se útil em reverter a insuficiência respiratória em pacientes selecionados, ou pelo menos em trazer conforto para pacientes hipoxêmicos que a princípio recusam a intubação endotraqueal / INTRODUCTION: Respiratory failure is a common situation among cancer patients leading to high rates of mortality. Noninvasive ventilation (NIV) can help its management, but its effects are still unknown regarding the pulmonary defense mechanisms. OBJECTIVES: Observe the effect of NIV with facial mask using a flow generator with continuous positive pressure (CPAP) and standard intensive care unit ventilator using pressure support ventilation + positive end expiratory pressure (PSV + PEEP), to verify impact on the physical properties of respiratory mucus and the comfort provided to the patient. METHODS: NIV was started after diagnosis of respiratory failure in nineteen patients, admitted in the intensive care unit of the A. C. Camargo Hospital. Nine patients were submitted to CPAP and ten to PSV + PEEP. Nasal mucus, blood gases, and the degree of comfort through a visual scale were accessed before and after one hour. The physical properties of nasal mucus (transportabilility in vitro, adhesivity and wettability or hydrofobicity) were evaluated respectively by frog palate, cough machine and contact angle. RESULTS: Groups had similar characteristics about age, sex, tumor and SAPS II score. Regarding the physical properties of the mucus, there was an increase in mucus transportability (by the frog palate model) with the system PSV + PEEP (p = 0.04) and an increase in the contact angle in the CPAP groupo (p = 0.06). The two systems were effective in improving the vital signs, the PaO2/FiO2, the respiratory pattern and comfort and avoiding endotracheal intubation in the first 24 hours (p < 0.05). However, regardless of the type of NIV system used, high rates of endotracheal intubation and mortality were found. CONCLUSION: The physical properties of the mucus (transportability in vitro and wettability) changed after an hour of use of the NIV as a result of temperature and humidification into the mask. NIV was useful in reversing the respiratory failure in selected patients, or at least in bringing comfort for those who refuse endotracheal intubation
|
129 |
Investigating the Driving Mechanisms Behind Differences in Bleaching and Disease Susceptibility Between Two Scleractinian Corals, Pseudodiploria Strigosa and Diploria LabyrinthiformisPratte, Zoe A 15 June 2015 (has links)
Disease and bleaching are two conditions which commonly lead to coral death. Among coral species, susceptibility to disease and bleaching is variable, and Pseudodiploria strigosa tends to be diseased more than Diploria labyrinthiformis, while D. labyrinthiformis bleaches more readily. The focus of this dissertation was to investigate and compare multiple components of these two coral species, and identify how they may relate to disease and bleaching resistance. Compenetnts examined included the surface mucopolysacharide layer (SML) thickness, gene expression, microbial associates, and a white plague aquarium study. The SML thickness decresased with increasing temperature regardless of coral species, indicating that SML thickness does not likely play a role in differences between susceptablities of these two coral species. However, Diploria labyrinthiformis had a lower mortality rate at 31°C, had fewer differentially expressed genes assossiated with stress, and upregulated genes associated with innate immunity in the summer, all of which may contribute to its relative disease resistance. The bacterial associates of each coral species were also monitored. Differences between the two coral species were primarily caused by Clostridia, Gammaproteobacteria, and rare species which may contribute to the relatively higher disease susceptibility of P. strigosa. Lastly, an aquarium study suggested that a potential pathogen of the Roseobacter clade infects both D. labyrinthiformis and P. strigosa, and might be transmitted by the Cryptochiridae gall crab, indicating that potential disease vectors associated with these two coral species may also play a role in disease resistance and resilience.
|
130 |
Mucins in the alimentary canal : their structure and interactions with polyphenolsDavies, Heather January 2014 (has links)
The polymeric gel-forming mucins provide the structural framework of saliva and the mucus barriers that cover the mucosal surfaces of the alimentary canal. Dietary compounds may influence the barrier properties of these protective layers. The effects of green tea polyphenols, which have many health benefits but have low bioavailability and contribute to the astringency of green tea, on the structural properties of the mucins in the alimentary canal are investigated here. Using well characterised, highly purified salivary mucins MUC5B and MUC7, and porcine gastric mucins, the effects of the green tea polyphenol epigallocatechin-3-gallate (EGCG) on mucins were studied here. Using rate-zonal centrifugation coupled to agarose gel electrophoresis, atomic force microscopy and particle tracking microrheology, EGCG, at concentrations found in a cup of green tea, caused increased aggregation of MUC5B in human whole saliva, and increased aggregation and viscosity of purified MUC5B. It was revealed using recombinant proteins of the N- and C-terminal regions of MUC5B that EGCG had these effects by aggregating the terminal globular protein domains of MUC5B. In contrast, MUC5B trypsin-resistant high molecular weight glycopeptides were not aggregated by EGCG, demonstrating that the oligosaccharide-rich, highly-glycosylated regions of mucins are not involved in the EGCG-induced aggregation of mucins. EGCG also caused the majority of MUC7 in human whole saliva to aggregate, and purified MUC7 also showed substantial aggregation in the presence of EGCG.Porcine gastric mucins were also used in order to model human gastric mucins. First, the identity of the porcine gastric mucins was explored using tandem mass spectrometry and immunohistochemistry. This revealed that Muc5ac was expressed by the surface epithelium and was the prominent mucin in porcine gastric mucus. Muc6 was expressed by gastric submucosal glands, but was not a major component of the secreted mucus barrier. Porcine Muc5ac and Muc6 were shown to be aggregated by EGCG. These data demonstrate that mucins from both saliva and the stomach are substantially altered by EGCG. This may contribute to the astringency and low bioavailability of EGCG. In contrast, the green tea polyphenol epicatechin (EC) did not cause aggregation of salivary mucins or porcine gastric mucins, suggesting that the galloyl ring of EGCG (which is absent in EC) is important for its aggregation of mucins, and that EC has different mechanisms of astringency. The structure of the mucins in the alimentary canal was studied using Raman spectroscopy, Raman optical activity (ROA) and Tip-enhanced Raman spectroscopy (TERS). The secondary structure of the oligosaccharide-rich regions of mucins was shown to be largely disordered, with some contribution of poly-proline II helix. The N- and C-terminal regions of MUC5B were largely β-sheet in structure, with some disordered structure also present in the C-terminal region. Raman spectroscopy could reliably distinguish between MUC5B glycoforms, demonstrating the sensitivity of this technique to mucin glycosylation and secondary structure. The first TERS spectra along the length of a MUC5B chain are reported, and suggest that patterns may exist in the glycosylation of MUC5B. Therefore, Raman spectroscopies are novel tools that shed new light on mucin structure and in future may be useful for studying the changes to mucin structure during interactions, such as those with polyphenols.
|
Page generated in 0.0348 seconds